Gut microbiome ecological topology as next-generation biomarkers for cancer immunotherapy.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 38906099.
- Also identified by DOI 10.1016/j.cell.2024.04.044.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Numerous studies have evaluated the gut microbiome as a biomarker for predicting cancer immunotherapy, but the heterogeneity among different studies has hindered its applications. In this issue of Cell, Derosa et al. report a biomarker based on the ecological topology of the gut microbiota that can predict immunotherapy efficacy effectively.
Medical subject headings
- Gastrointestinal Microbiome
- Immunotherapy
- Neoplasms
- Periodicals as Topic